Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure

Cellular Physiology and Biochemistry

Volumn 30, Issue 1, 2012, Pages 282-294

  Zelenak, Christine ^a   Pasham, Venkanna ^a   Jilani, Kashif ^a   Tripodi, Paola M ^b   Rosaclerio, Luisa ^b   Pathare, Ganesh ^a   Lupescu, Adrian ^a   Faggio, Caterina ^b   Qadri, Syed M ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Calcium; Cell membrane scrambling; Cell volume; Eryptosis; Phosphatidylserine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CERAMIDE; HEMOGLOBIN; LACTIC ACID; LIPOCORTIN 5; LUCIFERASE; LUCIFERIN; PHOSPHATIDYLSERINE; TANSHINONE IIA;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL VOLUME; CONTROLLED STUDY; CYTOSOL; ERYPTOSIS; ERYTHROCYTE; EXPOSURE; FLUORESCENCE; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR CELL;

SALVIA MILTIORRHIZA;

EID: 84863475409     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339064     Document Type: Article

References (100)

1. Guo Z J, Zhang Y, Tang X, Li H, Sun QS: Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats. Biol Pharm Bull 2008;31:1469-1474.
2. Li MH, Chen JM, Peng Y, Wu Q, Xiao PG: Investigation of Danshen and related medicinal plants in China. J Ethnopharmacol 2008;120:419-426. (Pubitemid 50322355)
3. Wang X, Morris-Natschke SL, Lee KH: New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 2007;27:133-148. (Pubitemid 44975189)
4. Liu JQ, Lee TF, Miedzyblocki M, Chan GC, Bigam DL, Cheung PY: Effects of tanshinone IIA, a major component of Salvia miltiorrhiza, on platelet aggregation in healthy newborn piglets. J Ethnopharmacol 2011;137:44-49.
5. Pan C, Lou L, Huo Y, Singh G, Chen M, Zhang D, Wu A, Zhao M, Wang S, Li J : Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Ther Adv CardiovascDis2011;
6. Zhang Y, Zhang L, Chu W, Wang B, Zhang J, Zhao M, Li X, Li B, Lu Y, Yang B, Shan H: Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes. Cell Physiol Biochem 2010;26:991-998.
7. Zhang Z, Zhang J, Jin L, SongT, Wu G, GaoJ: Tanshinone IIA interacts with DNA by minor groove-binding. Biol Pharm Bull 2008;31:2342-2345.
8. Ho JW, Jie M: Pharmacological activity of cardiovascular agents from herbal medicine. Cardiovasc Hematol Agents Med Chem 2007;5:273-277. (Pubitemid 47595737)
9. Slusarczyk S, Zimmermann S, Kaiser M, Matkowski A, Hamburger M, Adams M: Antiplasmodial and Antitrypanosomal Activity of Tanshinone-Type Diterpenoids from Salvia miltiorrhiza. Planta Med 2011;-in press.
10. Zhao J, Lou J, Mou Y, Li P, Wu J, Zhou L: Diterpenoid Tanshinones and Phenolic Acids from Cultured Hairy Roots of Salvia miltiorrhiza Bunge and Their Antimicrobial Activities. Molecules 2011;16:2259-2267.
11. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P: Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 2007;568:213-221. (Pubitemid 46976900)
12. Yang L, Zhang B, Yin L, Cai B, Shan H, Zhang L, Lu Y, Bi Z: Tanshinone IIA prevented brain iron dyshomeostasis in cerebral ischemic rats. Cell Physiol Biochem 2011;27:23-30.
13. Trinh HT, Chae S J, Joh EH, Son KH, Jeon S J, Kim DH: Tanshinones isolated from the rhizome of Salvia miltiorrhiza inhibit passive cutaneous anaphylaxis reaction in mice. J Ethnopharmacol 2010;132:344-348.
14. Chunming J, Miao Z, Cheng S, Nana T, Wei Z, Dongwei C, Yuan F: Tanshinone IIA Attenuates Peritoneal Fibrosis through Inhibition of Fibrogenic Growth Factors Expression in Peritoneum in a Peritoneal Dialysis Rat Model. Ren Fail 2011;33:355-362.
15. Li X, Du JR, Yu Y, Bai B, Zheng XY: Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway. J Ethnopharmacol 2010;129:273-279.
16. Tan X, Yang Y, Cheng J, Li P, Inoue I, Zeng X: Unique action of sodium tanshinone II-A sulfonate (DS-201) on the Ca(2+) dependent BK(Ca) activation in mouse cerebral arterial smooth muscle cells. Eur J Pharmacol 2011;656:27-32.
17. Tang FT, Cao Y, Wang TQ, Wang L J, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ: Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Eur J Pharmacol 2011;650:275-284.
18. Lu Y, Liu X, Liang X, Xiang L, Zhang W: Metabolomic strategy to study therapeutic and synergistic effects of tanshinone IIA, salvianolic acid B and ginsenoside Rbl in myocardial ischemia rats. J Ethnopharmacol 2011;134:45-49.
19. Sun D, Shen M, Li J, Li W, Zhang Y, Zhao L, Zhang Z, Yuan Y, Wang H, Cao F: Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3beta dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 2011;10:4.
20. Huang YF, Liu ML, Dong MQ, Yang WC, Zhang B, Luan LL, Dong HY, Xu M, Wang YX, Liu LL, Gao YQ, Li ZC: Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro. J Ethnopharmacol 2009;125:436-443.
21. Li J, Xu M, Fan Q, Xie X, Zhang Y, Mu D, Zhao P, Zhang B, Cao F, Wang Y, Jin F, Li Z: Tanshinone IIA ameliorates seawater exposure-induced lung injury by inhibiting aquaporins (AQP) 1 and AQP5 expression in lung. Respir Physiol Neurobiol 2011;176:39-49.
22. Li JH, Xu M, Xie XY, Fan QX, Mu DG, Zhang Y, Cao FL, Wang YX, Zhao PT, Zhang B, Jin FG, Li ZC: Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure. Clin Exp Pharmacol Physiol 2011;38:269-277.
23. Ahn YM, Kim SK, Lee SH, Ahn SY, Kang SW, Chung JH, Kim SD, Lee BC: Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease. Phytother Res 2010;24:1886-1892.
24. Liu YR, Qu SX, Maitz MF, Tan R, Weng J: The effect of the major components of Salvia Miltiorrhiza Bunge on bone marrow cells. J Ethnopharmacol 2007;111:573-583. (Pubitemid 46617102)
25. Liu T, Jin H, Sun QR, Xu JH, Hu HT: The neuroprotective effects of tanshinone IIA on beta-amyloid-induced toxicity in rat cortical neurons. Neuropharmacology 2010;59:595-604.
26. Shen JL, Chen YS, Lin JY, Tien YC, Peng WH, Kuo CH, Tzang BS, Wang HL, Tsai FJ, Chou MC, Huang CY, Lin CC: Neuron Regeneration and Proliferation Effects of Danshen and Tanshinone IIA. Evid Based Complement Alternat Med 2011;2011:378907.
27. Wang W, Zheng LL, Wang F, Hu ZL, Wu WN, Gu J, Chen JG: Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide. J Ethnopharmacol 2011;134:147-155.
28. Gong Y, Li Y, Lu Y, Li L, Abdolmaleky H, Blackburn GL, Zhou JR: Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. Int J Cancer 2011;129:1042-1052.
29. Jiao JW, Wen F: Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. Oncol Rep 2011;25:781-788.
30. Won SH, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Jung DB, Shin JM, Kwon TR, Yun SM, Lee MH, Choi SH, Lu J, Kim SH: Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway. Biol Pharm Bull 2010;33:1828-1834.
31. Zhang K, Li J, Meng W, Xing H, Yang Y: C/EBPbeta and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro. Int J Hematol 2010;92:571-578.
32. Elsharkawy AM, Oakley F, Mann DA: The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005;10:927-939. (Pubitemid 41285572)
33. Hong HJ, Liu JC, Cheng TH, Chan P: Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes. Acta Pharmacol Sin 2010;31:1569-1575.
34. Zhu B, Zhai Q, Yu B: Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol 2010;48:484-487.
35. Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO: Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 2006;542:1-7.
36. Fan G, Zhu Y, Guo H, Wang X, Wang H, Gao X: Direct Vasorelaxation by a Novel Phytoestrogen Tanshinone IIA Is Mediated by Nongenomic Action of Estrogen Receptor Through Endothelial Nitric Oxide Synthase Activation and Calcium Mobilization. J Cardiovasc Pharmacol 2011;57:340-347.
37. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Foller M: Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-380.
38. Foller M, Kasinathan RS, Koka S, Lang C, Shumilina E, Birnbaumer L, Lang F, Huber SM: TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell Physiol Biochem 2008;21:183-192.
39. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-1080.
40. Brugnara C, de Franceschi L, Alper SL: Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993;92:520-526. (Pubitemid 23209038)
41. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560. (Pubitemid 37429630)
42. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-1206. (Pubitemid 34048474)
43. Lang F, Gulbins E, Lang PA, Zappulla D, Foller M: Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010;26:21-28.
44. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T: Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 2005;118:1233-1243. (Pubitemid 40528693)
45. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder X Lang F: Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-C253.
46. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart J J, Montreuil J, Ameisen JC: Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-1156. (Pubitemid 34048470)
47. Mandal D, Moitra PK, Saha S, Basu J : Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 2002;513:184-188. (Pubitemid 34251261)
48. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D, Qadri SM, Lang F: p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-1286.
49. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F: Protein Kinase CKlalpha Regulates Erythrocyte Survival. Cell Physiol Biochem 2012;29:171-180.
50. Chen Y, Wu X, Yu S, Fauzee N J, Wu J, Li L, Zhao J, Zhao Y: Neuroprotective Capabilities of Tanshinone IIA against Cerebral Ischemia/Reperfusion Injury via Anti-apoptotic Pathway in Rats. Biol Pharm Bull 2012;35:164-170.
51. Chien SY, Kuo S J, Chen YL, Chen DR, Cheng CY, Su CC: Tanshinone IIA inhibits human hepatocellular carcinoma J 5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Mol Med Report 2012;5:282-286.
52. Qiao Z, Ma J, Liu H: Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules 2011;16:10002-10012.
53. Su CC, Chien SY, Kuo S J, Chen YL, Cheng CY, Chen DR: Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-kappaBp65. Mol Med Report 2012;5:1019-1022.
54. Xu S, Little P J, Lan T, Huang Y, Le K, Wu X, Shen X, Huang H, Cai Y, Tang F, Wang H, Liu P: Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet. Arch Biochem Biophys 2011;515:72-79.
55. Zhang Y, Won SH, Jiang C, Lee H J, Jeong S J, Lee EO, Zhang J, Ye M, Kim SH, Lu J : Tanshinones from Chinese Medicinal Herb Danshen (Salvia miltiorrhiza Bunge) Suppress Prostate Cancer Growth and Androgen Receptor Signaling. Pharm Res 2012;
56. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256. (Pubitemid 36553467)
57. Ganapathy V, Thangaraju M, Prasad PD: Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009;121:29-40.
58. Yoon Y, Kim YO, Jeon WK, Park H J, Sung HJ: Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 1999;68:121-127. (Pubitemid 29502468)
59. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243. (Pubitemid 38159647)
60. Bookchin RM, Ortiz OE, Lew VL: Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
61. Yang Y, Cai F, Li PY, Li ML, Chen J, Chen GL, Liu ZF, Zeng XR: Activation of high conductance Ca(2+)-activated K(+) channels by sodium tanshinonell-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells. Eur J Pharmacol 2008;598:9-15.
62. Arino T, Tanonaka K, Kawahara Y, Maki T, Takagi N, Yagi A, Takeo S: Effects of tanshinone VI on phosphorylation of ERKand Aktin isolated cardiomyocytes and cardiac fibroblasts. Eur J Pharmacol 2008;580:298-305.
63. Cheng CY, Su CC: Tanshinone IIA inhibits Hep-J 5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression. Int J Mol Med 2010;26:379-385.
64. Zhang R, Sun J, Ma L, Wu X, Pan G, Hao H, Zhou F, A J, Liu C, Ai H, Shang L, Gao H, Peng Y, Wan P, Wu H, Wang G: Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. Toxicol Appl Pharmacol 2011;252:18-27.
65. Wang X, Yeung JH: Inhibitory effect of tanshinones on rat CYP3A2 and CYP2C11 activity and its structure-activity relationship. Fitoterapia 2011;82:539-545.
66. Fang ZY, Lin R, Yuan BX, Yang GD, Liu Y, Zhang H: Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J Ethnopharmacol 2008;115:217-222. (Pubitemid 350266262)
67. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370. (Pubitemid 46671174)
68. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C, Nammi S, Henke G, Myssina S, Krikov M, Huber SM, Wieder T, Lang F: Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-477. (Pubitemid 39141524)
69. Lang PA, Beringer 0, Nicolay JP, Amon 0, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht C J, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-388. (Pubitemid 43673612)
70. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:273-281.
71. Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S, Shumilina E, Kempe DS, Tanneur V, Akel A, Lang KS, Foller M, Kun JF, Kremsner PG, Wesselborg S, Laufer S, Clemen CS, Herr C, Noegel AA, Wieder T, Gulbins E, Lang F, Huber SM: Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem 2009;24:415-428.
72. Siraskar B, Ballal A, Bobbala D, Foller M, Lang F: Effect of amphotericin B on parasitemia and survival of Plasmodium berghei-infected mice. Cell Physiol Biochem 2010;26:347-354.
73. Bobbala D, Alesutan I, Foller M, Huber SM, Lang F: Effect of anandamide in Plasmodium Berghei-infected mice. Cell Physiol Biochem 2010;26:355-362.
74. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F: Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-140.
75. Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F: Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2009;23:191-198.
76. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F: Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13:164-170.
77. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C, Jilani K, Siegfried A, Foller M, Lang F: Enhanced suicidal erythrocyte death in mice carrying a loss of function mutation of the Adenomatous Polyposis Coli gene. J Cell Mol Med 2011;
78. Zappulla D: Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to C02 increases? J Cardiometab Syndr 2008;3:30-34.
79. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F: Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-868.
80. Bhavsar SK, Eberhard M, Bobbala D, Lang F: Monensin induced suicidal erythrocyte death. Cell Physiol Biochem 2010;25:745-752.
81. Bhavsar SK, Gu S, Bobbala D, Lang F: Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-556.
82. Braun M, Foller M, Gulbins E, Lang F: Eryptosis triggered by bismuth. Biometals 2009;22:453-460.
83. Eberhard M, Ferlinz K, Alizzi K, Cacciato PM, Faggio C, Foller M, Lang F: FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem 2010;26:761-766.
84. Felder KM, Hoelzle K, Ritzmann M, Kilchling T, Schiele D, Heinritzi K, Groebel K, Hoelzle LE: Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol Biochem 2011;27:557-564.
85. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupee R, Rodemann HP, Ghoreschi K, Rocken M, Schaller M, Lang F, Wieder T: The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 2011;27:45-54.
86. Lang E, Jilani K, Zelenak C, Pasham V, Bobbala D, Qadri SM, Lang F: Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol Biochem 2011;28:347-354.
87. Mahmud H, Foller M, Lang F: Arsenic-induced suicidal erythrocyte death. Arch Toxicol 2009;83:107-113.
88. Mahmud H, Mauro D, Foller M, Lang F: Inhibitory effect of thymol on suicidal erythrocyte death. Cell Physiol Biochem 2009;24:407-414.
89. Mahmud H, Mauro D, Qadri SM, Foller M, Lang F: Triggering of suicidal erythrocyte death by amphotericin B. Cell Physiol Biochem 2009;24:263-270.
90. Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C, Kaestner L, Bernhardt I: Regulation of phosphatidylserine exposure in red blood cells. Cell Physiol Biochem 2011;28:847-856.
91. Qadri SM, Kucherenko Y, Zelenak C, Jilani K, Lang E, Lang F: Dicoumarol activates Ca2+-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol Biochem 2011;28:857-864.
92. Qadri SM, Bauer J, Zelenak C, Mahmud H, Kucherenko Y, Lee SH, Ferlinz K, Lang F: Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 2011;28:339-346.
93. Andrews DA, Low PS: Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82. (Pubitemid 29342520)
94. Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-302. (Pubitemid 29530214)
95. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS: Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-4627. (Pubitemid 36857838)
96. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, Bonomini M: Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709. (Pubitemid 350058263)
97. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-1880. (Pubitemid 26307087)
98. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidicacid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vase Biol 2007;27:414-421.
99. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988. (Pubitemid 40655614)
100. Kornhuber J, Tripal P, Reichel M, Muhle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E: Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 2010;26:9-20.